Addiction Statistics in Canada 2026 | Substances, Treatment & Key Health Facts

Addiction in Canada — The Scale of the Crisis

Addiction is one of the most urgent public health challenges Canada faces today. Across the country, substance use disorders (SUDs) affect millions of people — cutting across age groups, income levels, and communities — while straining healthcare systems, families, and the economy in ways that worsen each year. According to the Canadian Institute for Health Information (CIHI), approximately 1 in 5 Canadians experience a mental health or substance use issue in any given year, and roughly 1 in 3 will experience a mental illness over their lifetime. The total economic cost of addiction in Canada has reached an estimated $50.7 billion annually, incorporating healthcare expenditures, productivity losses, and criminal justice costs — rising to $65.9 billion when indirect social impacts are counted.

The 2026 picture of addiction in Canada is one of partial progress alongside persistent systemic failure. The opioid crisis saw a 17% decline in deaths in 2024, yet 7,146 Canadians still died from opioid toxicity that year — an average of 20 people every day. Treatment access remains deeply unequal: the average national wait time stands at 17.3 weeks, rising to 30 weeks in rural communities. Canada allocates just 6.3% of its healthcare budget to mental health and addictions — compared to 15% in France and 11% in Germany. The gap between the scale of the crisis and the adequacy of the national response remains wide and measurable.

Canada Addiction Key Facts & Statistics | 2026 Snapshot

Source: Health Canada Canadian Substance Use Survey 2023; Public Health Agency of Canada 2025; CIHI 2024–2025; Canadian Mental Health Association State of Mental Health 2024; Statistics Canada; ZipDo Canadian Addiction Statistics 2026

The headline figures in this snapshot expose the true breadth of addiction as a public health crisis in Canada. The $50.7 billion annual economic cost is a number that dwarfs the entire federal investment in addiction and mental health services, making the economic case for expanded treatment access as compelling as the moral one. Productivity losses alone, estimated at between $19.2 billion and $23.4 billion annually, represent money that leaves the economy through absenteeism, disability claims, premature death, and reduced workforce capacity — losses that disproportionately fall on employers, families, and provincial welfare systems. Healthcare costs attributable to addiction at $16.8 billion per year place the burden squarely on an already stretched public system.

The 82% comorbidity rate — the proportion of Canadians with a substance use disorder who also have a co-occurring mental health condition — is perhaps the most clinically significant figure in the dataset. Treating addiction without addressing underlying anxiety, depression, or PTSD is ineffective in the vast majority of cases. Yet Canada’s treatment infrastructure was largely built to address either mental health or addiction, rarely both together. Only 6.3% of Canada’s total healthcare budget is directed toward mental health and addiction combined — a figure the CMHA’s 2024 State of Mental Health report described as inadequate, noting that peer nations allocate between 9% and 15% of their health budgets to the same services.

Canada Opioid Crisis Statistics | Deaths, Fentanyl & Trends (2016–2024)

Apparent Opioid Toxicity Deaths in Canada — Annual Totals (2016–2024)
======================================================================
2016   2,832  █████████████
2017   3,981  ██████████████████
2018   4,614  █████████████████████
2019   3,823  █████████████████
2020   6,306  ████████████████████████████
2021   7,560  ██████████████████████████████████
2022   7,328  █████████████████████████████████
2023   8,606  ███████████████████████████████████████
2024   7,146  ████████████████████████████████ (−17%)

Source: Public Health Agency of Canada (PHAC) June 2025 Data Release; CBC News August 2025; ScienceDirect May 2025; Government of Canada Health Infobase December 2025

The opioid crisis in Canada has claimed more than 50,000 lives since 2016 — a death toll surpassing Canada’s military casualties in the Second World War. The 2024 figure of 7,146 deaths represents the first meaningful national decline since the crisis escalated, falling 17% from the 2023 peak of 8,606. Researchers have attributed this primarily to changes in the illegal drug supply, with evidence of a reduction in particularly toxic fentanyl combinations — notably opioids mixed with benzodiazepines — during 2024. That shift reflects dynamics driven by drug trafficking organisations rather than any single policy intervention, a fragility noted by public health officials in the Government of Canada’s joint statement in June 2025.

The geographic distribution of opioid deaths in 2024 is as important as the national total. 80% of all opioid toxicity deaths occurred in just three provinces — British Columbia, Alberta, and Ontario — though all three saw declines from 2023. Meanwhile, Quebec, the Northwest Territories, and Newfoundland and Labrador all recorded increases, a pattern that underlines how uneven the crisis remains across the country. Fentanyl’s involvement in approximately 74% of opioid deaths in 2024 is largely unchanged from prior years, confirming that the synthetic opioid remains the driving force of the crisis despite years of law enforcement focus on supply interception. Hospitalizations related to opioid poisoning also fell in 2024, declining 15% to 5,514 patients nationally, with emergency room visits and first-responder callouts both down approximately 15% as well.

Canada Alcohol & Cannabis Use Statistics | Prevalence by Population (2023)

Past-12-Month Substance Use Among Canadians Aged 15+ (CSUS 2023)
=================================================================
Alcohol             ████████████████████████████████████████████████████  79%
Cannabis            ████████████████████████████████████████  32%
Sedatives           ████████████████████  13%
Opioids             ████████████████████  13%
Cigarettes (30-day) ████████████████████  13%
Vaping (30-day)     ████████████████  10%
Stimulants          ████████  5%

Source: Health Canada Canadian Substance Use Survey (CSUS) 2023, published December 2024; Statistics Canada CCHS 2021; Canadian Cannabis Survey 2024

Alcohol remains by far the most widely used and most economically costly substance in Canada, with a 90% lifetime prevalence among the adult population and 79% of Canadians reporting use in the past 12 months. The 5.3% of Canadians aged 15 and older who meet clinical criteria for alcohol use disorder (AUD) represent a large but often under-counted population, partly because stigma around alcohol misuse remains a significant barrier to help-seeking. 15.6% of Canadians aged 12 and older engaged in heavy drinking patterns in 2021, down from 19.2% in 2015 — a meaningful improvement, though still representing millions of individuals at risk of alcohol-related health harm. Alcohol-caused hospitalisations occur at a rate of 249 per 100,000 Canadians — a figure comparable to the rate for heart attacks — underscoring the severity of alcohol’s impact on the health system.

Cannabis use has grown substantially since legalisation under the Cannabis Act in 2018, with 32% of Canadians aged 15+ reporting past-year use in 2023 — up from lower pre-legalisation baselines. Among youth and young adults, the figures are more pronounced: 48% reported lifetime cannabis use and 28% vaped cannabis products in the past 30 days. 5.5% of Canadians report using cannabis daily or almost daily, a rate that has remained stable since 2019, while 4.7% of past-year cannabis consumers showed signs of impaired control over their use. Despite this, only 5% of lifetime cannabis users felt they needed professional help, and just 3% had ever received it — pointing to a significant unmet need that Canada’s public health infrastructure is not yet equipped to address at scale.

Canada Addiction Demographics | High-Risk Populations & Disparities (2022–2024)

SUD Prevalence — Relative Risk by Demographic Group (vs. General Population)
=============================================================================
Youth aged 18–25               ██████████████████████████████████  11.2% (highest)
Indigenous peoples (AUD)       ██████████████████████████  2.3x higher risk
Trans/non-binary individuals   ████████████████████████  2.8x higher SUD risk
Low-income Canadians           ████████████████████  1.9x higher SUD risk
LGB individuals                ██████████████████  1.4–1.25x higher risk
Low-education adults           ████████████████  2.3x higher SUD risk

Source: ZipDo Canadian Addiction Statistics 2026; Statistics Canada CCHS 2021; Health Canada; CIHI; WorldMetrics Canadian Addiction Statistics 2026

The demographic disparities in addiction across Canada are among the most consistent and troubling findings in the national data. Indigenous peoples bear a disproportionate burden at virtually every level of the addiction landscape — from the 2.3 times higher prevalence of alcohol use disorder relative to non-Indigenous Canadians, to First Nations youth being four times more likely to be hospitalised for substance use-related issues. These disparities are not the product of cultural predisposition but of structural determinants rooted in colonisation, ongoing marginalisation, inadequate housing, poverty, and the intergenerational trauma of residential schools — factors explicitly acknowledged in the Government of Canada’s June 2025 joint statement on substance harms. Indigenous women in urban settings face the compounded risk of a 3.1 times higher AUD rate than their non-Indigenous urban counterparts, a figure that speaks to intersecting vulnerabilities.

Youth aged 18–25 represent the highest-SUD-prevalence age group in Canada at 11.2%, a figure that has remained elevated and is accompanied by particularly alarming data on suicidal ideation. Adolescents with substance use disorders are five times more likely to report suicidal ideation than those without, a co-occurrence that reflects the tight clinical relationship between early-onset addiction and mood disorder. Despite this, medications to treat opioid use disorder (OUD) among youth are underprescribed across Canada, with Ontario recording prescription rates at their lowest level in 2024 even as the province’s opioid death rate had grown by 369% since 2013. The data for transgender and non-binary Canadians — who show 2.8 times the SUD prevalence of cisgender individuals — is particularly underreported and understudied, pointing to a significant gap in both research and targeted service provision.

Canada Addiction Treatment Statistics | Access, Wait Times & Spending (2023–2025)

Canada Addiction Treatment System — Key Gaps at a Glance
=========================================================
Avg. national wait (weeks)    17.3  ████████████████████████████████████████████████
Rural wait time (weeks)       30.0  ████████████████████████████████████████████████████████████████████
Unmet treatment need (%)      35.2  █████████████████████████████████████████████████████████████████████
SUD not accessing treatment   45%   ████████████████████████████████████████████████████████████████████████████████
Mental health budget share     6.3% ██████████████
France comparison             15%   ████████████████████████████████████████████████████████████████████████████████████████████████████

Source: CIHI Mental Health and Substance Use Services 2024 & 2025; Canadian Mental Health Association 2024; Canadian Affairs January 2025; ZipDo 2026; Health Canada

The treatment access gap in Canada is one of the starkest expressions of the policy failure at the heart of the addiction crisis. An average national wait of 17.3 weeks for publicly funded addiction treatment — stretching to 30 weeks in rural regions — means that many people who reach out for help are forced to wait through the most critical and vulnerable window of their recovery motivation. 45% of Canadians with a substance use disorder do not access treatment in any given year, and 35.2% of those with a SUD explicitly report unmet treatment needs due to limited service availability. The Canadian Institute for Health Information found in its 2023–2024 data that 1 in 10 people seeking community mental health counselling waited 143 days or more — nearly five months — for care.

The funding picture behind these access failures is unambiguous. A December 2024 report from the Canadian Alliance on Mental Illness and Mental Health revealed that provinces had allocated an average of just 16% of the $25 billion in federal healthcare transfers toward mental health and addiction services between 2023 and 2026 — a figure already below the federal government’s stated expectations. Three provinces — British Columbia, Manitoba, and Prince Edward Island — allocated zero per cent of federal transfers to mental health and substance use, while three more allocated 10% or less. Only 22% of Canadian provinces operate 24/7 addiction treatment hotlines, despite the fact that 40% of calls for addiction support arrive outside business hours. These structural deficiencies compound daily for the estimated 8 million Canadians experiencing a substance use or mental health issue in any given year.

Canada Addiction & Mental Health Comorbidity Statistics | Dual Diagnosis (2022–2024)

Mental Health Conditions Among Canadians with SUD (2022)
=========================================================
Any comorbid mental disorder    ████████████████████████████████████████████████████████████████████████████████████  82%
Depression with AUD             ████████████████████████████████████████████████████████████████████████  45%
Anxiety with AUD                ██████████████████████████████████████████████████████████████████████████████████████  55%
Schizophrenia with SUD          █████████████████████████████████████████  25.1%
Bipolar disorder with SUD       ████████████████████████████████████████  20.1%

Source: CIHR 2022; CIHI 2025; PubMed / Statistics Canada; Canadian Mental Health Association State of Mental Health 2024; PHAC 2022; ZipDo Canadian Addiction Statistics 2026

The 82% comorbidity rate between substance use disorders and mental health conditions in Canada is a clinical and policy reality that changes the fundamental approach required to address addiction effectively. This figure — drawn from 2022 national data — means that for the overwhelming majority of Canadians living with addiction, there is a co-occurring mental health condition that must be identified and treated in parallel, or recovery outcomes will be severely compromised. The specific combinations are instructive: 45% of Canadians with depression also live with alcohol use disorder, and 55% of those with AUD have a lifetime history of anxiety disorder — patterns that suggest alcohol is frequently being used as a self-medication strategy for untreated mood and anxiety conditions. This cycle of self-medication followed by physical dependence is the clinical pathway through which many Canadians first develop a diagnosable SUD.

The data on severe mental illness is equally stark. Among Canadians living with schizophrenia, the prevalence of a co-occurring SUD is 25.1%; among those with bipolar disorder, it reaches 20.1% — rates far above the general population baseline. Yet treatment for this population remains among the most difficult to access, partly due to a system architecture that still routes people into either psychiatric care or addiction treatment depending on which condition presents first. The Canadian Mental Health Association’s 2024 report identified mental health status in Canada as three times worse than pre-pandemic levels, a deterioration that has directly accelerated substance use across the country. Stigma remains a significant structural barrier — 30% of Canadians with both a SUD and a mental illness cite stigma as a primary reason for not seeking care, a finding that underlines the continued need for public education and destigmatisation alongside clinical system reform.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE